StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.45+0.30 (+13.95%)

Close on Nov 17, 2026Market cap $106.08MP/E –Yield –

NRX Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

NRX Pharmaceuticals's price to book ratio was 5.2× on Apr 28, 2023, against 4.4× a year earlier. Over the last 3 years it ranged from 1.2× to 113.4×, with a median of 63.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 20235.2×+0.7
2022Dec 30, 20224.5×−73.7
2021Jul 30, 202178.2×+4.6
2020Jan 31, 202073.6×+0.6
2019Dec 31, 201973.0×+7.1
2018Dec 31, 201865.9×–

More NRX Pharmaceuticals figures

See a number that looks wrong?